Loading...
NYSE: MDT
Medtronic plc
Healthcare · Medical - Devices
●S&P 500 since 1986
Market Cap
$111.97B
52w High
$106.33
52w Low
$79.55
P/E
24.23
Volume
4.51M
Outstanding Shares
1.28B
Company profile
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
CEOGeoffrey Straub Martha
SectorHealthcare
IndustryMedical - Devices
Employees95,000
IPO dateMay 2, 1973
Valuation
Forward P/E—
EV/EBITDA14.59
Enterprise value$134.49B
Stock splits
Sep 27, 19992:1
Sep 15, 19972:1
Sep 29, 19952:1
Sep 30, 19942:1
Aug 30, 19912:1
Aug 31, 19892:1
Aug 1, 19802:1
Profitability & growth
Revenue growth8.76%
Gross margin61.95%▼0.04%vs FY2024
Operating margin17.86%▲11.72%vs FY2024
ROE9.71%▲32.61%vs FY2024
Analyst consensus
RatingBuy
Target price$111.45▲27.79%
27
Buy
22
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 20, 2026
View
EPS
Actual vs estimate by quarter
Q1FY26
ActualEst.
$1.26
$1.23
Q2FY26
ActualEst.
$1.36
$1.31
Q3FY26
ActualEst.
$1.36
$1.34
Q4FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q1FY26
ActualEst.
$8.58B
$8.38B
Q2FY26
ActualEst.
$8.96B
$8.87B
Q3FY26
ActualEst.
$9.02B
$8.91B
Q4FY26
Next Est.
—